Doctorsa, a Milan-based healthtech platform, has closed a €1 million seed funding round led by PranaVentures, with participation from Vento and 40Jemz Ventures. The capital injection marks a significant milestone for the young startup, which was founded in 2023 and has already established itself as a bridge between travelers and healthcare providers across 40 countries.
The Italian startup offers a digital healthcare solution specifically designed for people traveling abroad. Through its platform, users can access 24/7 telemedicine consultations with licensed doctors starting at just €20. The service integrates artificial intelligence for intelligent agent-based booking, streamlining the process of connecting patients with appropriate medical professionals regardless of their location.
Expansion Plans Take Center Stage
The fresh capital will be deployed strategically across three main initiatives. Doctorsa plans to consolidate its presence in current markets while simultaneously accelerating its international expansion, with particular emphasis on entering the United States market. Beyond serving individual travelers, the startup is developing dedicated B2B offerings targeting travel operators, insurance companies, and corporate wellness programs—a move that could substantially broaden its revenue streams and market reach.
According to Nadia Neytcheva, CEO of Doctorsa, the company’s philosophy diverges from traditional healthcare models. “For years, healthcare has asked people to adapt to its processes. We believe it should be the opposite. We aim to make quick access to a trusted doctor a natural part of the travel experience,” Neytcheva stated, highlighting the startup’s user-centric approach to solving a tangible problem in the travel and health sectors.
Addressing a Market Need
The funding announcement reflects growing investor confidence in digital health solutions that address specific use cases. Travelers frequently face challenges accessing reliable medical care in unfamiliar territories, whether dealing with minor ailments or unexpected health complications. Doctorsa’s platform eliminates geographical barriers and language obstacles that typically complicate healthcare access abroad, creating a clear value proposition for its target users.
The startup’s focus on both B2C and B2B segments positions it to capture value across multiple customer categories. Travel operators can integrate telemedicine services as a value-added feature, while insurers and employers can leverage the platform to provide comprehensive health coverage for their constituents.
European Healthtech Momentum
Doctorsa’s successful funding round exemplifies the continued vitality of Europe’s healthtech sector, where startups are solving real-world problems at the intersection of travel, wellness, and digital services. With backing from established venture capital firms including PranaVentures, the startup joins a growing cohort of European digital health companies expanding beyond continental borders, particularly toward the lucrative American market where telemedicine adoption continues to accelerate.
BODY_END